Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclobutyrol SCHEMBL9558905 | 0.98 | CHRM2 (0.35) | CHRM2CHRM1CHRM3CHRM4ALDH1A1 | |
| Cyclobutyrol SCHEMBL28086622 | 0.98 | CHRM2 (0.35) | CHRM2CHRM1CHRM3CHRM4ALDH1A1 | |
| Cyclobutyrol SCHEMBL10559593 | 0.98 | CHRM2 (0.35) | CHRM2CHRM1CHRM3CHRM4ALDH1A1 | |
| SCHEMBL314898 | 0.98 | MME (0.34) | CHRM2CHRM1CHRM3CHRM4ALDH1A1 | |
| SCHEMBL1186169 | 0.93 | TSHR (0.35) | CHRM2CHRM1CHRM3CHRM4ALDH1A1 | |
| SCHEMBL664693 | 0.83 | CHRM2 (0.35) | CHRM2CHRM1CHRM3CHRM4ALDH1A1 | |
| Cyclohexane SCHEMBL4027710 | 0.83 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1CYP2C19PPARAMME | |
| Cyclobutyrol SCHEMBL1649614 | 0.82 | CHRM2 (0.34) | CHRM2CHRM1CHRM3CHRM4ALDH1A1 | |
| SCHEMBL10951781 | 0.80 | CA2 (0.42) | CHRM2CHRM1CHRM3CHRM4MME | |
| SCHEMBL25429426 | 0.79 | PPARA (0.33) | ALDH1A1L3MBTL1CYP2C19PPARAMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180125986-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2018-05-10 | — | — | US | claimed |
| EP-2501368-B1 | A PROCESS FOR CONVERTING A SOLID (METH)ACRYLATE COPOLYMER INTO A DISPERSED FORM BY MEANS OF A DISPERSING AGENT | EVONIK ROEHM GMBH (DE) | 2018-04-18 | — | — | EP | claimed |
| US-20160076062-A1 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | XYLECO, INC. | 2016-03-17 | — | — | US | claimed |
| US-9284416-B2 | Process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent | EVONIK ROEHM GMBH (DE) | 2016-03-15 | — | — | US | claimed |
| CN-105247060-A | Processing biomass to obtain hydroxycarboxylic acids | XYLECO INC | 2016-01-13 | — | — | CN | claimed |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2015-11-19 | — | — | US | claimed |
| EP-2890794-A2 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | Xyleco, Inc. (US) | 2015-07-08 | — | — | EP | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| WO-2014176508-A2 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | XYLECO, INC. (US) | 2014-10-30 | — | — | WO | claimed |
| WO-2014111957-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | SATYAM APPARAO (IN) | 2014-07-24 | — | — | WO | claimed |
| US-20120208832-A1 | PROCESS FOR CONVERTING A SOLID (METH)ACRYLATE COPOLYMER INTO A DISPERSED FORM BY MEANS OF A DISPERSING AGENT | EVONIK ROEHM GMBH (DE) | 2012-08-16 | — | — | US | claimed |
| WO-2011057676-A1 | A PROCESS FOR CONVERTING A SOLID (METH)ACRYLATE COPOLYMER INTO A DISPERSED FORM BY MEANS OF A DISPERSING AGENT | EVONIK RÖHM GMBH (DE) | 2011-05-19 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180125986-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | NOS2, NOS1, NOS3 | CHRM2 549/4885CHRM1 379/4885CHRM3 477/4885 |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | NOS2, NOS1, PTGIS | CHRM2 495/4885CHRM1 361/4885CHRM3 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.